South Korea considers Poison Pills

13 November 2009

Sarah Wilson

EU regulation

The Korean Justice Ministry stated this week that Korea has 'made hostile M&A attacks easy by removing a ceiling on foreign stock investments, but it has not had any means to prevent hostile M&A'. It has announced public hearings to consider proposals to provide for the use of poison pills. Reuters reported that business groups have called for a clause to allow an acquisition target to issue new shares to designated shareholders at a preset low price, thus diluting the ownership value for a hostile bidder.

Further Reading

South Korea Considers Letting Companies Use Poison Pills

Latest News

SHareholder meeting

US SEC warning chills investor stewardship

SHareholder meeting

US State officials raise stewardship concerns over Rule 14a-8 rescission

SHareholder meeting

Investment Association calls for hybrid formats in virtual AGM adoption

SHareholder meeting

SEC quorum rules overhaul raises fresh shareholder rights concerns

SHareholder meeting

FCA opts for comply-or-explain climate disclosures in retreat from mandatory reporting

SHareholder meeting

SEC’s Tesla decision risks accelerating retail voting programme adoption

Featured Briefings

Minerva Briefing

2026 Global Proxy Season Review

Minerva Briefing

Global IPOs: Growth, governance and risk

Minerva Briefing

Shareholder Proposal Voting Trends 2026 H1

Minerva is a global provider of sustainable stewardship solutions with over 30 years of expertise. Minerva empowers investors by providing essential tools, including ESG research and data and expert insights, enabling them to navigate the intricate and ever-evolving landscape of stewardship and proxy voting, whilst ensuring their decisions are well-informed and aligned with sustainable principles.

Related Stories

No items found.